Digital Pharma Innovation Week has ended
avatar for Mark Reisenauer

Mark Reisenauer

Senior Vice President, Oncology Business Unit
Mark Reisenauer is senior vice president of the Astellas US oncology business unit. He leads all commercial activities for Oncology in the US–including marketed products and commercial planning for late-stage development compounds. 
Prior to joining Astellas in 2011, Mark served as senior vice president and chief commercial officer of Micromet Inc. (now part of Amgen), where he led investor and public relations, new product planning, and commercial launch planning. Previously, Reisenauer held various sales and marketing leadership roles at Abbott, Pharmacia, Bristol-Myers Squibb, and AstraZeneca.  
Mark earned a bachelor’s degree in political science from the University of Wisconsin.